REPORT HIGHLIGHT
Intravenous solutions market was valued at USD 8.94 billion by 2019, growing with 9.8% CAGR during the forecast period, 2020-2026.

Market Dynamics

The intravenous solution includes water, electrolytes, and glucose in the form of a physiological saline solution and glucose solution, having essential micro and macronutrients. Intravenous solutions are directly introduced in the veins as it is the fastest route of fluid delivery. This IV solution has the same osmotic pressure as blood, it does not impart any pressure of the blood vessels even if it is infused in the blood for a longer time. It may also include amino-acid and lipids in varying concentrations. As per the Faculty of Health Centre for Rural Health (Australia), more than 75% of patients admitted into hospital are receiving some type of IV therapy. IV solutions are available in various forms based on the presence of ingredients and their functions. Basic IV solution, nutrient solution, and special infusion solution are some of the product types.

The market is experiencing growth on the grounds of the rise in medical conditions such as cholera, diarrhoea, food-related infections, cancer, hepatitis, resulting in increased patient numbers in hospital admission. According to the World Health Organization (WHO), approximately 1.3 million to 4.0 million people across the world suffered from cholera in 2019. Also, the organization stated that cancer is the second leading cause of death globally, accounted for more than 9.6 million deaths in 2018. IV therapy is recommended by physicians during the treatment protocol for patients who have such chronic conditions, augmenting the industry growth to a great extent.

Furthermore, this therapy is an ideal option for patients suffering from dehydration, diarrhoea, and nutritional deficiency. The rising number of patients with these conditions would, in turn, further stimulates the product demand. Other factors such as new product developments, aging population, rising number of premature births, and malnutrition will create the demand for intravenous solutions, supporting the industry development.

On the counter side, products such as antibiotics and medications used in IV therapy are highly regulated by governments in order to ensure quality and availability to consumers. Strict government regulations coupled with the lack of reimbursement policies hinder the growth of this market. In addition to this, the high cost of vitamin C intravenous therapy is expected to hamper the market growth to some extent.

Solution Type Takeaway

Based on the solution types, the market has been categorized into Lactated Ringer’s, mixed solutions, vitamins & minerals, amino acid, dextran, heparin & trace elements, and saline (normal and hypertonic saline). Among these, the amino acid category dominated the market growth in 2019 as it acts as a building block for body growth. The amino acid infused intravenous solution helps in maintaining the metabolic pathways. On the other hand, Lactated Ringer’s segment is projected to grow with promising CAGR over the future period. It is estimated that 70% of the total IV product range comes from dextrose with normal saline, dextrose 5%, and ringer lactate. All these are available in glass as well as plastic containers.

Bag Type Takeaway

On the basis of bag types, the market is bifurcated into large and small volume bags. Large volume bags (i.e. greater than 250ml) dominated the overall market revenue in 2019. Growing demand for large quantities of IV solution to settle the electrolyte imbalance, deliver essential nutrients and drugs is creating the demand for large volume bags. Furthermore, an increasing number of medical surgeries coupled with hike in patients with chronic disease conditions that demands continuous nutrient supply fuel the segment growth during the study period. On the contrary, the small volume category is projected to grow with promising CAGR over the study period.

Type Takeaway

Depending upon types, the industry is divided into total parenteral nutrition and peripheral parenteral nutrition. Total parenteral nutrition held more than 50% of the total market share in 2019, owing to a better source of providing total nutrition when compared to peripheral parental nutrition. It is a more preferred option than peripheral nutrition to deliver nutrition in a higher concentration of essential components for a longer period of time.

Rising prevalence of digestive disorders, hike in malnutrition cases underdeveloped regions will further create a huge opportunity for this product. According to the United Nations Children’s Fund (UNICEF), the prevalence of malnutrition remains alarming and impacting the lives of many young children in developing regions as well as some developed countries. The World Health Organization revealed that around 462 million people globally are underweight, whereas 45% of child death is often associated with under-nutrition or malnutrition mainly from middle and low-income countries. Such facts will fuel product demand during the future period.

Application Takeaway

Irrigation, nutritional, basic, blood, and drug IV solution are some of the key application areas for this product. In 2019, a basic IV solution emerged as a promising application for the intravenous solution. It is commonly used types as it mainly includes glucose and saline solution with amino acids with the prime purpose to provide water as well as essential solutions to the body. The rise in hospitalization for various infectious diseases and medical conditions is driving demand for basic IV solution for delivering essential nutrients.

End-use Takeaway

On the basis of end-use, the market is further classified into ambulatory, hospitals & clinics, and home care. The hospital achieved a dominating position in 2019 owing to the rise in outpatient volume with upgrading the quality of healthcare services. Technological advancement in the healthcare sector coupled with the rising chronic diseases further drives the segment growth. Ongoing development towards boosting hospital infrastructure to offer more advanced treatment and increase hospital capacity to settle rising outpatient admissions also favors the product demand for hospitals.

Key Vendor Takeaway

Some of the key players that are actively responsible for the growth of this industry are ICU Medical, Baxter International, Grifols, B. Braun Melsungen AG, Fresenius Kabi, JW Life Science, Vifor Pharma Management Limited, Salius Pharma Pvt. Ltd., Axa Parenterals, and Amanta Healthcare.

To alleviate the shortage of the IV solutions key companies are actively operational for increasing production facilities. For instance, in 2019, B. Braun Medical announced an investment of USD 1 billion for construction or expansion of the manufacturing facilities dedicated to production IV fluids. Prominent players are also involved in a strategic collaboration to expand their market presence. In February 2017, ICU Medical acquired the Hospira Infusion Systems business from Pfizer Inc. This acquisition has helped the company to increase its product offering in I.V. solutions, pumps, and devices. In addition, through innovation, key vendors are engaged in developing premixed products for easy use and reduce packaging waste.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year – 2015 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2026
TARGET AUDIENCE

Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

INTRAVENOUS SOLUTION PLATFORM MARKET KEY PLAYERS

Axa Parenterals Ltd
ICU Medical
JW Life Science
Amanta Healthcare
Baxter International
Fresenius Kabi
Vifor Pharma Management
Braun Melsungen AG
Grifols, S.A.
Salius Pharma Private Limited
GLOBAL INTRAVENOUS SOLUTION PLATFORM MARKET BY SOLUTION TYPE

Amino Acid
Dextran
Lactated Ringer’s
Saline
Normal Saline (0.9% NaCl)
Hypertonic Saline
Vitamins & Minerals
Mixed Solutions
Heparin and Trace Elements
GLOBAL INTRAVENOUS SOLUTION PLATFORM MARKET, BY BAG TYPE

Large Volume Bags (Greater Than 250ml)
Small Volume Bags (Less Than 250ml)
GLOBAL INTRAVENOUS SOLUTION PLATFORM MARKET, BY TYPE

Peripheral Parenteral Nutrition
Total Parenteral Nutrition
GLOBAL INTRAVENOUS SOLUTION PLATFORM MARKET, BY APPLICATION

Drug IV Solution
Basic IV Solution
Blood IV Solution
Irrigation IV Solution
Nutritional IV Solution
GLOBAL INTRAVENOUS SOLUTION PLATFORM MARKET, BY END-USE

Ambulatory
Home Care
Hospital & Clinics
GLOBAL INTRAVENOUS SOLUTION PLATFORM MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Singapore
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East and Africa
Saudi Arabia
United Arab Emirates
Rest of MEA